يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Yoshihito Kogure"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1
    A Randomized Phase III Study of Pembrolizumab Versus Pembrolizumab-Carboplatin-Pemetrexed for Locally Advanced or Metastatic Nonsquamous Non-small-cell Lung Cancer with PD-L1 50% or more (LAPLACE-50): Study Protocol

    المؤلفون: Masahide Oki, Hiroya Hashimoto, Yoshihito Kogure

    المصدر: Clinical Lung Cancer. 22:e921-e924

    مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Pemetrexed, Pembrolizumab, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Anaplastic lymphoma kinase, Lung cancer, business.industry, Area under the curve, Combination chemotherapy, medicine.disease, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::631ec8c2da179bfc51236a35d25b7886Test
    https://doi.org/10.1016/j.cllc.2021.02.008Test


    أضف إلى المفضلة
  2. 2
    A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)

    المؤلفون: Terufumi Kato, Yasutaka Watanabe, D. Fujimoto, Kaname Nosaki, Masayuki Takeda, Mototsugu Shimokawa, Hiroshi Tanaka, Kazuo Hasegawa, Atsushi Nakamura, Naohiko Hamaguchi, Koichi Azuma, Isamu Okamoto, Daisuke Hayakawa, Kakuhiro Yamaguchi, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Motoko Tachihara, Toshiaki Takahashi, Yoshihito Kogure

    المصدر: Clinical Lung Cancer. 22:376-380

    مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.drug_class, medicine.medical_treatment, Phases of clinical research, Tyrosine-kinase inhibitor, Central Nervous System Neoplasms, Cohort Studies, 03 medical and health sciences, T790M, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Osimertinib, Prospective Studies, Lung cancer, Acrylamides, Chemotherapy, Aniline Compounds, business.industry, Standard treatment, medicine.disease, Progression-Free Survival, respiratory tract diseases, ErbB Receptors, 030104 developmental biology, 030220 oncology & carcinogenesis, Mutation, Cohort, Disease Progression, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f1217b6719037c7d3a691311cec275dTest
    https://doi.org/10.1016/j.cllc.2020.12.009Test


    أضف إلى المفضلة
  3. 3
    A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol

    المؤلفون: Yuichi Takiguchi, Noriyuki Ebi, Takayasu Kurata, Yukito Ichinose, Takashi Seto, Takeharu Yamanaka, Shinji Atagi, Kaoru Kubota, Hideo Saka, Yoshihito Kogure, Akira Inoue, Mitsuhiro Takenoyama, Akiko Kada, Akihiko Gemma, Nobuyuki Yamamoto, Masahiko Ando

    المصدر: Clinical lung cancer. 19(5)

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Paclitaxel, medicine.medical_treatment, Docetaxel, Vinorelbine, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Albumins, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Medicine, Humans, 030212 general & internal medicine, Lung cancer, Aged, Aged, 80 and over, Chemotherapy, business.industry, Standard treatment, medicine.disease, Prognosis, Gemcitabine, Survival Rate, chemistry, Research Design, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, business, medicine.drug, Follow-Up Studies

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0d8b4842d04b3993c273a939bdd0ea2Test
    https://pubmed.ncbi.nlm.nih.gov/29861395Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث